SCHEMBL9256691

SCHEMBL9256691

CC(C)CCSCCC(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.64
KMT2A Q03164 1/20 0.64
HSD17B10 Q99714 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
BHMT Q93088 10/20 0.52
TSHR P16473 2/20 0.46
BHMT2 Q9H2M3 1/20 0.46
GABRP O00591 2/20 0.43
GABRD O14764 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRB1 P18505 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA5 P31644 2/20 0.43
GABRA3 P34903 2/20 0.43
GABRA2 P47869 2/20 0.43
GABRB2 P47870 2/20 0.43
GABRA4 P48169 2/20 0.43
GABRE P78334 2/20 0.43
GABRA6 Q16445 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27465045 0.84 BHMT (0.64) LMNAKMT2AHSD17B10TDP1BHMT
SCHEMBL867489 0.84 BHMT (0.54) LMNAKMT2AHSD17B10TDP1BHMT
SCHEMBL9777669 0.84 BHMT (0.54) LMNAKMT2AHSD17B10TDP1BHMT
SCHEMBL12055908 0.81 LMNA (0.56) LMNAKMT2AHSD17B10TDP1BHMT
E388 SCHEMBL28962323 0.80 LMNA (1.00) LMNAKMT2AHSD17B10TDP1BHMT
E388 SCHEMBL28696 0.80 LMNA (1.00) LMNAKMT2AHSD17B10TDP1BHMT
SCHEMBL1405521 0.79 BHMT (0.53) LMNAKMT2AHSD17B10TDP1BHMT
SCHEMBL19792798 0.79 LMNA (0.59) LMNAKMT2AHSD17B10TDP1BHMT
SCHEMBL19800803 0.78 BHMT (0.72) BHMTBHMT2
SCHEMBL19800800 0.78 BHMT (0.72) BHMTBHMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021075741-A1 QUANTUM DOTS, CURABLE COMPOSITION COMPRISING SAME, CURED FILM MANUFACTURED USING COMPOSITION, AND COLOR FILTER COMPRISING CURED FILM 삼성에스디아이 주식회사 2021-04-22 WO disclosed
US-10556919-B2 Limonene-based, non-halogenated flame retardants for polymeric applications INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-02-11 US disclosed
US-20190169213-A1 LIMONENE-BASED, NON-HALOGENATED FLAME RETARDANTS FOR POLYMERIC APPLICATIONS INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-06-06 US disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169213-A1 LIMONENE-BASED, NON-HALOGENATED FLAME RETARDANTS FOR POLYMERIC APPLICATIONS LIMK1, PFAS, LIMA1 LMNA 316/4885KMT2A 1678/4885HSD17B10 1525/4885
US-10556919-B2 Limonene-based, non-halogenated flame retardants for polymeric applications LIMK1, PFAS, LIMA1 LMNA 316/4885KMT2A 1678/4885HSD17B10 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.